A Phase 1 Clinical Trial of High Dose AAV1.SERCA2a in Patients with Heart Failure: Modulation of SERCA2a of Intramyocytic Calcium trafficking in Heart Failure with Reduced Ejection Fraction (MUSIC-HFrEF)

被引：0
|
作者：
Jaski, Brian [1 ]
Cheng, Richard [2 ]
Rudy, Jeffrey [3 ]
Li, Ronald A. [4 ]
Hajjar, Roger [3 ]
机构：
[1] San Diego Cardiac Ctr, San Diego, CA USA
[2] Univ Calif San Francisco, San Francisco, CA USA
[3] Sardocor Corp, Boston, MA USA
[4] Medera Inc, Boston, MA USA
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
5
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [21] Evaluation of the Long-Term Effects of AAV1/SERCA2a Gene Therapy on Clinical Events in Heart Failure Patients Using a Novel Statistical Model: Results and Implications for Future Trials
    Greenberg, Barry
    Yaroshinsky, Alex
    Dittrich, Howard
    Rudy, Jeff
    Zsebo, Krisztina
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (08) : S59 - S59
  • [22] Gene transfer of SERCA2a by intracoronary delivery of adeno-associated virus type 1 vector in a pre-clinical model of heart failure
    Kawase, Yoshiaki
    Ly, Hung Q.
    Prunier, Fabrice
    Lebeche, Djamel
    Shi, Yanfen
    Yoneyama, Ryuichi
    Hoshino, Kozo
    Takewa, Yoshiaki
    Tardif, Jean-Claude
    Levine, Robert A.
    Tanguay, Jean-Francois
    Hajjar, Roger J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 83A - 83A
  • [23] Interleukin-1 Blockade in Heart Failure With Preserved Ejection Fraction: The Diastolic Heart Failure Anakinra Response Trial 2 (DHART2)
    Van Tassell, Benjamin
    Canada, Justin
    Buckley, Leo
    Carbone, Salvatore
    Trankle, Cory
    Del Buono, Marco
    Dixon, Dave
    Kadariya, Dinesh
    Billingsley, Hayley
    Park, Tae Shik
    Vo, Chau
    Dessie, Sofanit
    Arena, Ross
    Abbate, Antonio
    CIRCULATION, 2017, 136
  • [24] Augmentation of left ventricular mechanics by recirculation-mediated AAV2/1-SERCA2a gene delivery in experimental heart failure
    Mariani, Justin A.
    Smolic, Anka
    Preovolos, Arthur
    Byrne, Melissa J.
    Power, John M.
    Kaye, David M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (03) : 247 - 253
  • [25] Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals
    Byrne, M. J.
    Power, J. M.
    Preovolos, A.
    Mariani, J. A.
    Hajjar, R. J.
    Kaye, D. M.
    GENE THERAPY, 2008, 15 (23) : 1550 - 1557
  • [26] Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals
    M J Byrne
    J M Power
    A Preovolos
    J A Mariani
    R J Hajjar
    D M Kaye
    Gene Therapy, 2008, 15 : 1550 - 1557
  • [27] Calotropin attenuates ischemic heart failure after myocardial infarction by modulating SIRT1/FOXD3/SERCA2a pathway
    Chen, Zijing
    Yao, Haojie
    Yao, Xiaowei
    Zheng, Ruiyan
    Yang, Ying
    Liu, Zhongqiu
    Zhang, Rongrong
    Cheng, Yuanyuan
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 179
  • [28] SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway
    Kumarswamy, Regalla
    Lyon, Alexander R.
    Volkmann, Ingo
    Mills, Adam M.
    Bretthauer, Julia
    Pahuja, Aanchal
    Geers-Knoerr, Cornelia
    Kraft, Theresia
    Hajjar, Roger J.
    Macleod, Kenneth T.
    Harding, Sian E.
    Thum, Thomas
    EUROPEAN HEART JOURNAL, 2012, 33 (09) : 1067 - 1075
  • [29] Effects of Elamipretide on Left Ventricular Function in Patients With Heart Failure With Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial
    Butler, Jonah
    Khan, Muhammad Shahzeb
    Anker, Stefan D.
    Fonarow, Gregg C.
    Kim, Raymond J.
    Nodari, Savina
    O'Connor, Christopher M.
    Pieske, Burkert
    Pieske-Kraigher, Elisabeth
    Sabbah, Hani N.
    Senni, Michele
    Voors, Adriaan A.
    Udelson, James E.
    Carr, Jim
    Gheorghiade, Mihai
    Filippatos, Gerasimos
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (05) : 429 - 437
  • [30] Change in Diuretic Dose After Initiation of a SGLT2 Inhibitor in Patients with Heart Failure with Reduced Ejection Fraction
    Wildemann, R.
    Karalis, D. G.
    Mirachi, N.
    Thoma, B.
    D'Angelo, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S340 - S340
12345